PGK1 protein promotes brain tumor formation and cancer metabolism

March 3, 2016

PGK1, a glycolytic enzyme, has been found to play a role in coordinating cellular processes crucial to cancer metabolism and brain tumor formation, according to results published in today's online issue of Molecular Cell. The findings may lay the groundwork for improved approaches to diagnosis and treatment of glioblastoma and other cancers.

The study, led by The University of Texas MD Anderson Cancer Center, showed that PGK1, which is associated with tumor metastasis and drug resistance, was instrumental in glycolysis and the cycle, both important for generating the energy that feeds . The paper sheds further light on the Warburg effect, an enzymatic pathway that cancer cells employ to boost energy levels and produce cellular substances that lead to rapid cancer growth.

"The Warburg effect promotes tumor progression. Exactly how this is coordinated has remained elusive," said Zhimin Lu, M.D., Ph.D., professor of Neuro-Oncology. "Our study highlights that PGK1 acts as a protein kinase in coordinating glycolysis and the citric acid cycle in and ."

Normal cells generate oxygen for survival via a relatively low rate of glycolysis, which converts glucose into the enzyme pyruvate. Pyruvate is used in the citric acid cycle (TCA), a series of chemical reactions that generate energy.

Cancer cells however produce energy by a high rate of glycolysis followed by lactic acid fermentation in the cell, a process that converts glucose into cellular energy and forms lactic acid. Normal healthy cells will bypass this fermentation process if oxygen is available. Malignant, rapidly growing tumors can experience glycolytic rates up to 200 times higher than those of healthy cells and will undergo fermentation even in the presence of high oxygen levels.

"The Warburg effect is characterized by increased levels of glucose, lactate production and suppression of pyruvate metabolism in mitochondria," said Lu. "Exactly how this process is coordinated with cancer metabolism has been little understood."

Lu's team found that a cellular chain of events involving activation of cancer genes like EGFR, KRAS and B-Raf and the protein ERK, allowed PGK1 to "translocate" into the cell's mitochondria. Mitochondria are membrane-containing cell components crucial for producing energy. PGK1 acted as a in mitochondria and activated a critical enzyme that inhibited the mitochondria's ability to use pyruvate, suppressed chemically reactive molecules containing oxygen and increased lactate levels.

"Our findings provided critical insight into the Warburg effect and demonstrates that PGK1 ultimately promotes cancer cell proliferation and tumor formation," said Lu. "It may help us to develop a molecular basis for improved diagnosis and treatment of cancer."

Explore further: Novel regulatory mechanism for cell division found

Related Stories

Link between colon cancer and metabolism identified

May 13, 2014

More than 60 years ago Otto Warburg recognized that cancer cells differ from normal cells in the metabolic pathway they use for the oxidation of sugar. Rather than the typical series of oxidative steps that take place in ...

Study reveals new insight into DNA repair

August 3, 2015

DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy. New information published this week reveals more about why this occurs and how these breaks ...

Recommended for you

A new way to slow cancer cell growth

May 25, 2017

Cancer is an extremely complex disease, but its definition is quite simple: the abnormal and uncontrollable growth of cells. Researchers from the University of Rochester's Center for RNA Biology have identified a new way ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.